{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:45:47Z","timestamp":1790729147091,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.idc.2020.10.009","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T19:03:35Z","timestamp":1607367815000},"page":"199-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Skin and Soft Tissue Infections in Non\u2013Human Immunodeficiency Virus Immunocompromised Hosts"],"prefix":"10.1016","volume":"35","author":[{"given":"Shivan","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Shelburne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0891-5520(05)70164-1","article-title":"Dermatologic infections in the immunocompromised (non-HIV) host","volume":"15","author":"Lopez","year":"2001","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QCO.0000000000000632","article-title":"The skin and soft tissue infections in hematological patients","volume":"33","author":"Ungaro","year":"2020","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamasurg.2013.173","article-title":"Immunocompromised status in patients with necrotizing soft-tissue infection","volume":"148","author":"Keung","year":"2013","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib4","first-page":"450","article-title":"Effect of underlying immune compromise on the manifestations and outcomes of group a streptococcal bacteremia","volume":"74","author":"Linder","year":"2017","journal-title":"J\u00a0Infect"},{"issue":"3","key":"10.1016\/j.idc.2020.10.009_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/649866","article-title":"Escherichia coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies","volume":"50","author":"Vigil","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.009_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cmi.2017.08.016","article-title":"Acute disseminated candidiasis with skin lesions: a systematic review","volume":"24","author":"Guarana","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"26","key":"10.1016\/j.idc.2020.10.009_bib7","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1097\/MD.0000000000001018","article-title":"Cutaneous invasive aspergillosis: retrospective multicenter study of the French Invasive-Aspergillosis Registry and literature review","volume":"94","author":"Bernardeschi","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/QCO.0000000000000378","article-title":"Approach to skin and soft tissue infections in non-HIV immunocompromised hosts","volume":"30","author":"Burke","year":"2017","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/QCO.0000000000000630","article-title":"Fungal infections of the skin and soft tissue","volume":"33","author":"Gunaydin","year":"2020","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2020.10.009_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11908-018-0621-1","article-title":"Cutaneous manifestations of infections in solid organ transplant recipients","volume":"20","author":"Pettit","year":"2018","journal-title":"Curr Infect Dis Rep"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s15010-013-0525-9","article-title":"The current spectrum of infection in cancer patients with chemotherapy related neutropenia","volume":"42","author":"Nesher","year":"2014","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.idc.2020.10.009_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.hoc.2017.08.004","article-title":"Neutropenic fever","volume":"31","author":"White","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cid\/cix687","article-title":"Call for action: invasive fungal infections associated with ibrutinib and other small molecule kinase inhibitors targeting immune signaling pathways","volume":"66","author":"Chamilos","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00128071-200607010-00003","article-title":"Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies","volume":"7","author":"Tan","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.idc.2020.10.009_bib15","doi-asserted-by":"crossref","first-page":"100091","DOI":"10.1016\/j.jctube.2019.100091","article-title":"Nontuberculous mycobacterial infections of the lower extremities: a 15-year experience","volume":"15","author":"Diaz","year":"2019","journal-title":"J\u00a0Clin Tuberc Other Mycobact Dis"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3314\/mmj.19.008","article-title":"Cutaneous cryptococcosis","volume":"60","author":"Noguchi","year":"2019","journal-title":"Med Mycol J"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2020.10.009_bib17","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkp074","article-title":"The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years","volume":"63","author":"Bodey","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3960\/jslrt.51.115","article-title":"A\u00a0case of intravascular lymphoma complicated with Fournier\u2019s syndrome due to multidrug-resistant Pseudomonas aeruginosa","volume":"51","author":"Kaya","year":"2011","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.idc.2020.10.009_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008133","article-title":"Necrotising fasciitis caused by p aeruginosa in a male patient with chronic lymphocytic leukaemia","volume":"2013","author":"Emmett","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib20","first-page":"497","article-title":"Pyomyositis in the united states 2002-2014","volume":"80","author":"Maravelas","year":"2020","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10096-014-2277-6","article-title":"Ecthyma gangrenosum and ecthyma-like lesions: review article","volume":"34","author":"Vaiman","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2020.10.009_bib22","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/cid\/ciy825","article-title":"Fluoroquinolone prophylaxis selects for meropenem-nonsusceptible Pseudomonas aeruginosa in patients with hematologic malignancies and hematopoietic cell transplant recipients","volume":"68","author":"Hakki","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib23","doi-asserted-by":"crossref","first-page":"e02494-19","DOI":"10.1128\/AAC.02494-19","article-title":"Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa","volume":"64","author":"Gudiol","year":"2020","journal-title":"Antimicrobial Agents Chemother"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijantimicag.2018.11.001","article-title":"Ceftolozane\/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience","volume":"53","author":"Bassetti","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.diagmicrobio.2017.03.001","article-title":"Increased risk of death with recurrent Pseudomonas aeruginosa bacteremia","volume":"88","author":"McCarthy","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2020.10.009_bib26","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/cid\/ciz223","article-title":"Antibiotic therapy for Pseudomonas aeruginosa bloodstream infections: how long is long enough?","volume":"69","author":"Fabre","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"31","key":"10.1016\/j.idc.2020.10.009_bib28","doi-asserted-by":"crossref","first-page":"e4375","DOI":"10.1097\/MD.0000000000004375","article-title":"Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia","volume":"95","author":"Jeon","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.idc.2020.10.009_bib29","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2008.11.003","article-title":"Stenotrophomonas maltophilia infections of intact skin: a systematic review of the literature","volume":"63","author":"Bin Abdulhak","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.009_bib30","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/cncr.21846","article-title":"Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients","volume":"106","author":"Boktour","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5021\/ad.2009.21.4.389","article-title":"Ecthyma gangrenosum: a rare cutaneous manifestation caused by Stenotrophomonas maltophilia in a leukemic patient","volume":"21","author":"Son","year":"2009","journal-title":"Ann Dermatol"},{"issue":"12","key":"10.1016\/j.idc.2020.10.009_bib32","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/522998","article-title":"Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer","volume":"45","author":"Safdar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.10.009_bib33","article-title":"Alterations of the oral microbiome and cumulative carbapenem exposure are associated with Stenotrophomonas maltophilia infection in patients with acute myeloid leukemia receiving chemotherapy","author":"Aitken","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib34","doi-asserted-by":"crossref","first-page":"e01603-19","DOI":"10.1128\/JCM.01603-19","article-title":"Activity of potential alternative treatment agents for Stenotrophomonas maltophilia isolates nonsusceptible to levofloxacin and\/or trimethoprim-sulfamethoxazole","volume":"58","author":"Biagi","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib35","doi-asserted-by":"crossref","first-page":"e01955-19","DOI":"10.1128\/AAC.01955-19","article-title":"Activity of cefiderocol and comparators against isolates from cancer patients","volume":"64","author":"Rolston","year":"2020","journal-title":"Antimicrobial Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s15010-019-01369-4","article-title":"The clinical impact of Stenotrophomonas maltophilia bacteremia on the 30-day mortality rate in patients with hematologic disorders: a single-institution experience","volume":"48","author":"Bao","year":"2020","journal-title":"Infection"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2020.10.009_bib37","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenic cancer patients","volume":"30","author":"Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.idc.2020.10.009_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib39","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib40","first-page":"23","article-title":"Gram-negative bacteria as emerging pathogens affecting mortality in skin and soft tissue infections","volume":"22","author":"Ioannou","year":"2018","journal-title":"Hippokratia"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciy1011","article-title":"High mortality of non-Fournier necrotizing fasciitis with enterobacteriales: time to rethink classification?","volume":"69","author":"Kuehl","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2020.10.009_bib42","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1080\/10428194.2016.1193859","article-title":"The growing threat of multidrug-resistant gram-negative infections in patients with hematologic malignancies","volume":"57","author":"Baker","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.idc.2020.10.009_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijid.2014.05.024","article-title":"Monomicrobial necrotizing fasciitis in a single center: the emergence of gram-negative bacteria as a common pathogen","volume":"28","author":"Yahav","year":"2014","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.009_bib44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cmi.2018.05.008","article-title":"Monomicrobial Klebsiella pneumoniae necrotizing fasciitis: an emerging life-threatening entity","volume":"25","author":"Rahim","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.idc.2020.10.009_bib45","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00277-020-04061-y","article-title":"Necrotizing fasciitis in haematological patients: a different scenario","volume":"99","author":"Albasanz-Puig","year":"2020","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.idc.2020.10.009_bib47","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.idc.2020.10.009_bib48","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/cid\/ciz173","article-title":"A\u00a0primer on AmpC beta-lactamases: necessary knowledge for an increasingly multidrug-resistant world","volume":"69","author":"Tamma","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.009_bib49","doi-asserted-by":"crossref","first-page":"ofaa051","DOI":"10.1093\/ofid\/ofaa051","article-title":"Real-world multicenter analysis of clinical outcomes and safety of meropenem-vaborbactam in patients treated for serious gram-negative bacterial infections","volume":"7","author":"Alosaimy","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib50","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1186\/s12879-019-4409-1","article-title":"Efficacy of ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant enterobacteriaceae","volume":"19","author":"Alraddadi","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000329661","article-title":"Incidence of fluoroquinolone-resistant and extended-spectrum beta-lactamase-producing Escherichia coli at a comprehensive cancer center in the united states","volume":"57","author":"Bhusal","year":"2011","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ijantimicag.2016.12.016","article-title":"In\u00a0vitro activity of ceftaroline and comparator agents against gram-positive and gram-negative clinical isolates from cancer patients","volume":"49","author":"Rolston","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib53","doi-asserted-by":"crossref","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mayocp.2012.06.029","article-title":"Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study","volume":"88","author":"Wentworth","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib55","doi-asserted-by":"crossref","first-page":"e00069-18","DOI":"10.1128\/CMR.00069-18","article-title":"Cutaneous mycobacterial infections","volume":"32","author":"Franco-Paredes","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.idc.2020.10.009_bib56","first-page":"311","article-title":"Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation","volume":"4","author":"Al-Anazi","year":"2014","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin Chest Med"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib58","doi-asserted-by":"crossref","first-page":"387 e1","DOI":"10.1016\/j.jhsa.2017.10.030","article-title":"Nontuberculous mycobacterial infections of the upper extremity: 15-year experience at a tertiary care medical center","volume":"43","author":"Sotello","year":"2018","journal-title":"J\u00a0Hand Surg Am"},{"key":"10.1016\/j.idc.2020.10.009_bib59","doi-asserted-by":"crossref","first-page":"e13315","DOI":"10.1111\/tid.13315","article-title":"Mycobacterium haemophilum skin and soft tissue infection in a kidney transplant recipient: a case report and summary of the literature","author":"Jurairattanaporn","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.009_bib60","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3201\/eid2509.190430","article-title":"Clinical characteristics and treatment outcomes for patients infected with mycobacterium haemophilum","volume":"25","author":"Nookeu","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cup.12903","article-title":"Clinical and histopathological features of cutaneous nontuberculous mycobacterial infection: a review of 13 cases","volume":"44","author":"Li","year":"2017","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib62","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.009_bib63","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/cid\/cis1032","article-title":"Management of rapidly growing mycobacterial bacteremia in cancer patients","volume":"56","author":"El Helou","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2020.10.009_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11908-019-0684-7","article-title":"Updates on nocardia skin and soft tissue infections in solid organ transplantation","volume":"21","author":"Hemmersbach-Miller","year":"2019","journal-title":"Curr Infect Dis Rep"},{"issue":"6","key":"10.1016\/j.idc.2020.10.009_bib65","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QCO.0000000000000404","article-title":"Nocardia infections in solid organ and hematopoietic stem cell transplant recipients","volume":"30","author":"Coussement","year":"2017","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib66","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/CMR.19.2.259-282.2006","article-title":"Clinical and laboratory features of the nocardia spp. Based on current molecular taxonomy","volume":"19","author":"Brown-Elliott","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib67","first-page":"44","article-title":"Experience with linezolid for the treatment of nocardiosis in organ transplant recipients","volume":"70","author":"De La Cruz","year":"2015","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib68","doi-asserted-by":"crossref","first-page":"ofaa090","DOI":"10.1093\/ofid\/ofaa090","article-title":"Safety and outcomes of linezolid use for nocardiosis","volume":"7","author":"Davidson","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2020.10.009_bib69","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant-associated infection surveillance network (transnet) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2020.10.009_bib70","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (transnet)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.10.009_bib71","doi-asserted-by":"crossref","first-page":"e00691","DOI":"10.1016\/j.idcr.2019.e00691","article-title":"Rapidly progressive necrotizing cellulitis secondary to candida tropicalis infection in an immunocompromised host","volume":"19","author":"Krishnan","year":"2020","journal-title":"IDCases"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib72","first-page":"265","article-title":"The diagnostic yield of skin biopsy in patients with leukemia and suspected infection","volume":"67","author":"Farmakiotis","year":"2013","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib73","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2020.10.009_bib74","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3201\/eid2011.140685","article-title":"Drug-resistant candida glabrata infection in cancer patients","volume":"20","author":"Farmakiotis","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib75","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/313987","article-title":"Candidal meningitis in children with cancer","volume":"31","author":"McCullers","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.009_bib76","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/QCO.0000000000000603","article-title":"Candida auris: what have we learned so far?","volume":"32","author":"Corsi-Vasquez","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.009_bib77","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/myc.12928","article-title":"Dermatological manifestations of fungal infection in patients with febrile neutropaenia: a review of the literature","volume":"62","author":"Maddy","year":"2019","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib78","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jaad.2018.04.059","article-title":"Angioinvasive fungal infections impacting the skin: background, epidemiology, and clinical presentation","volume":"80","author":"Shields","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.idc.2020.10.009_bib79","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/342328","article-title":"Cutaneous infection by fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management","volume":"35","author":"Nucci","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib80","first-page":"331","article-title":"Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009","volume":"60","author":"Campo","year":"2010","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib81","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaad.2018.04.058","article-title":"Angioinvasive fungal infections impacting the skin: diagnosis, management, and complications","volume":"80","author":"Berger","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.idc.2020.10.009_bib82","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/cid\/ciy473","article-title":"Breakthrough invasive mold infections in the hematology patient: current concepts and future directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib83","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2020.10.009_bib84","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-5945-10-10","article-title":"Successful treatment of fusarium solani ecthyma gangrenosum in a patient affected by leukocyte adhesion deficiency type 1 with granulocytes transfusions","volume":"10","author":"Mellouli","year":"2010","journal-title":"BMC Dermatol"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib85","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11908-013-0352-2","article-title":"Cutaneous manifestations of endemic mycoses","volume":"15","author":"Smith","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.idc.2020.10.009_bib86","doi-asserted-by":"crossref","DOI":"10.1007\/s11046-020-00431-2","article-title":"Re-drawing the maps for endemic mycoses","author":"Ashraf","year":"2020","journal-title":"Mycopathologia"},{"issue":"11","key":"10.1016\/j.idc.2020.10.009_bib87","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1086\/345724","article-title":"Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the united states and brazil","volume":"186","author":"Karimi","year":"2002","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.009_bib88","doi-asserted-by":"crossref","first-page":"e13553","DOI":"10.1111\/ctr.13553","article-title":"Endemic fungal infections in solid organ transplant recipients-guidelines from the American Society of Transplantation Infectious Diseases community of practice","volume":"33","author":"Miller","year":"2019","journal-title":"Clin Transplant"},{"issue":"12","key":"10.1016\/j.idc.2020.10.009_bib89","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1128\/CVI.00071-07","article-title":"Detection of histoplasma antigen by a quantitative enzyme immunoassay","volume":"14","author":"Connolly","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib90","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.idc.2015.10.002","article-title":"Blastomycosis","volume":"30","author":"Castillo","year":"2016","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.idc.2020.10.009_bib91","first-page":"E18","article-title":"North American blastomycosis in an immunocompromised patient","volume":"104","author":"Patel","year":"2019","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/CVI.05248-11","article-title":"Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay","volume":"19","author":"Connolly","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib93","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1590\/abd1806-4841.20153805","article-title":"Coccidioidomycosis and the skin: a comprehensive review","volume":"90","author":"Garcia Garcia","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"7","key":"10.1016\/j.idc.2020.10.009_bib94","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the infectious diseases society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2020.10.009_bib95","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1086\/588300","article-title":"Clinical practice guidelines for the management of blastomycosis: 2008 update by the infectious diseases society of America","volume":"46","author":"Chapman","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2020.10.009_bib96","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2020.10.009_bib97","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.trre.2017.03.001","article-title":"Cutaneous fungal infections in solid organ transplant recipients","volume":"31","author":"Ilyas","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"issue":"3","key":"10.1016\/j.idc.2020.10.009_bib98","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of crantyptococcal disease: 2010 update by the infectious diseases society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.009_bib99","doi-asserted-by":"crossref","first-page":"e13543","DOI":"10.1111\/ctr.13543","article-title":"Cryptococcosis in solid organ transplantation-guidelines from the American Society of Transplantation Infectious Diseases community of practice","volume":"33","author":"Baddley","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.idc.2020.10.009_bib100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcv.2017.08.007","article-title":"Cutaneous infections from viral sources in solid organ transplant recipients","volume":"97","author":"Ilyas","year":"2017","journal-title":"J\u00a0Clin Virol"},{"issue":"10","key":"10.1016\/j.idc.2020.10.009_bib101","first-page":"38","article-title":"The \"knife-cut sign\" revisited: a distinctive presentation of linear erosive herpes simplex virus infection in immunocompromised patients","volume":"8","author":"Cohen","year":"2015","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib102","doi-asserted-by":"crossref","DOI":"10.5070\/D3262047422","article-title":"A\u00a0case of atypical disseminated herpes simplex virus 1 with hepatitis in a liver transplant recipient: the need for dermatologic evaluation","volume":"26","author":"Fernandez-Nieto","year":"2020","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.idc.2020.10.009_bib103","doi-asserted-by":"crossref","first-page":"104421","DOI":"10.1016\/j.jcv.2020.104421","article-title":"Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients","volume":"128","author":"Anton-Vazquez","year":"2020","journal-title":"J\u00a0Clin Virol"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib104","doi-asserted-by":"crossref","first-page":"ofaa121","DOI":"10.1093\/ofid\/ofaa121","article-title":"Infectious complications following cd19 chimeric antigen receptor t-cell therapy for children, adolescents, and young adults","volume":"7","author":"Vora","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.009_bib105","doi-asserted-by":"crossref","first-page":"e13526","DOI":"10.1111\/ctr.13526","article-title":"Herpes simplex virus infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases community of practice","volume":"33","author":"Lee","year":"2019","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.idc.2020.10.009_bib106","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/QCO.0000000000000288","article-title":"Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management","volume":"29","author":"Piret","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2020.10.009_bib107","doi-asserted-by":"crossref","first-page":"e13622","DOI":"10.1111\/ctr.13622","article-title":"Varicella zoster virus in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases community of practice","volume":"33","author":"Pergam","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.idc.2020.10.009_bib108","article-title":"High incidence of herpes zoster after cord blood hematopoietic cell transplant despite longer duration of antiviral prophylaxis","author":"Xue","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2020.10.009_bib109","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.idc.2020.10.009_bib110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"van Griensven","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2020.10.009_bib111","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/ced.13061","article-title":"Cutaneous leishmaniasis associated with anti-tumour necrosis factor-alpha drugs: an emerging disease","volume":"42","author":"Marcoval","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.idc.2020.10.009_bib112","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12867","article-title":"Leishmaniasis in solid organ and hematopoietic stem cell transplant recipients","volume":"31","author":"Gajurel","year":"2017","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib113","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/11310730-000000000-00000","article-title":"Neutrophilic dermatoses: a review of current treatment options","volume":"10","author":"Cohen","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1016\/j.idc.2020.10.009_bib114","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2012.02.024","article-title":"Necrotizing sweet syndrome: a new variant of neutrophilic dermatosis mimicking necrotizing fasciitis","volume":"67","author":"Kroshinsky","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089155202030088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089155202030088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:18:15Z","timestamp":1760195895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089155202030088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S089155202030088X"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2020.10.009","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin and Soft Tissue Infections in Non\u2013Human Immunodeficiency Virus Immunocompromised Hosts","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2020.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}